Moffitt at ASH
The 64th installment of the American Society of Hematology (ASH) Annual Meeting will be held at the Ernest N. Morial Convention Center in New Orleans, Louisiana – and broadcast virtually – from December 10-13, 2022.
Moffitt's nationally lauded Malignant Hematology Program specializes in the diagnosis and treatment of blood cancers and autoimmune disorders, and we are dedicated to providing exceptional care by developing a tailored treatment plan for each patient. This year, Moffitt authors were listed on 156 abstracts that showcased the latest advances in hematology. In total, there were 57 oral and poster presentations presented by Moffitt authors, three scientific symposia featuring Moffitt speakers.
To learn more about Moffitt's research and breakthroughs, follow Moffitt on Twitter (@MoffittNews) and LinkedIn or subscribe to our newsletters and don't forget to stop by our Booth #1922 when you are at ASH.
2021 Featured Articles - Stay Tuned for 2022 Updates
Moffitt Study Shows Benefit to Giving CAR T-cell Therapy to Patients Sooner
Using cell therapy as a second-line treatment provided better outcomes for lymphoma patients compared to standard of care.
Does Intensifying Lymphodepletion Impact CAR T-Cell Therapy?
Study investigates increasing duration and dosage of chemotherapy in patients with B-cell malignancies.
Do Racial and Ethnic Differences Impact Outcomes in Multiple Myeloma?
“A lot of the genetic and molecular differences we found have direct therapeutic implications,” Moffitt study shows.
UltraCAR-T™ Shows Promise for Treating Myeloid Malignancies
Fast-acting treatment aims to extend lives when minutes matter.
For additional information on Moffitt’s research presented at ASH please reach out to:
Kim Polacek, APR, CPRC
Senior PR Account Coordinator